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Introduction
Abdominal infection leading to sepsis is a major cause of
mortality in the ICU. The inflammatory response also
alters the pulmonary immunity leading to increased risk
for VAP.
Objectives
The aim of this study was to determine the incidence of
VAP and define the most important pathogens for VAP in
patients with abdominal sepsis.
Methods
A retrospective study in a 7 bedded mixed medical surgi-
cal ICU of a tertiary care teaching institute.
The data of patients diagnosed with abdominal sepsis
between 2009 & 2013 and requiring mechanical ventila-
tion for at least 48 hours was extracted. The microbiologi-
cal flora as assessed by sampling of endotracheal aspirate
(ETA) for culture and sensitivity were noted. The Clinical
Pulmonary Infection Score (CPIS) was used to make the
diagnosis of VAP.
Results
The average age of the 124 patients (59 males and
65 females) recruited in the study was 58 years (range 27-
76 years) and mean APACHE II was 19 (range 9-30). The
average length of ICU stay was 16 days (range 4-57 days)
and the duration of mechanical ventilation was 12.5 days;
39 patients (31.4%) died. In patients with abdominal sepsis,
67 strains of bacteria were cultivated from the lower
respiratory tract, of which 62 were Gram-negative.
All of these bacterial strains were isolated in significant
quantities for lower respiratory tract infection. The most
common bacteria isolated from the endotracheal aspirate
were Klebsiella pneumoniae (24 times), followed by
Pseudomonas aeruginosa (22 times) and Acinetobacter
baumannii (16 times). VAP was diagnosed in 47 patients
(37.9%) in the cohort. The incidence of VAP was calcu-
lated to be 93.6 per 1000 days of mechanical ventilation.
In 34 patients (72.3%), VAP was diagnosed as early onset
( < 4 days of initiation of mechanical ventilation) and in 13
patients (27.7%) as late onset (>4 days).
Conclusions
Despite advances in diagnostics and therapy, abdominal
sepsis is still burdened with high morbidity and mortality
due to VAP. Therefore, the prevention and treatment of
VAP remains an integral component in the management
of mechanically ventilated patients of abdominal sepsis.
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